Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN hepatology committee position statement

Journal of Pediatric Gastroenterology and Nutrition

Volumn 60, Issue 4, 2015, Pages 550-561

  Nobili, Valerio ^a   Vajro, Pietro ^b   Dezsofi, Antal ^c   Fischler, Bjorn ^d   Hadzic, Nedim ^e   Jahnel, Joerg ^f   Lamireau, Thierry ^g   McKiernan, Patrick ^h   McLin, Valerie ⁱ   Socha, Piotr ^j   Tizzard, Sarah ^e   Baumann, Ulrich ^k  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g Department of Neuropediatrics   (France)

^h BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

ⁱ Faculty of Medicine   (Switzerland)

^j CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^k HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

bariatric surgery; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; obesity

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CHILD; CHILDHOOD OBESITY; COMORBIDITY; DISEASE SEVERITY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GASTRIC BALLOON; GASTRIC BANDING; HEPATITIS; HUMAN; INFORMED CONSENT; LIVER FIBROSIS; LONG TERM CARE; MALABSORPTION; MALABSORPTIVE SURGICAL PROCEDURE; NONALCOHOLIC FATTY LIVER; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STEATOSIS; STOMACH BYPASS; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT REDUCTION; ADULT; COMPLICATION; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PATHOLOGY; PROCEDURES;

ADOLESCENT; ADULT; BARIATRIC SURGERY; CHILD; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; WEIGHT LOSS;

EID: 84927177420     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000715     Document Type: Article

References (113)

1. Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond) 2007;31:1-14.
2. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010;7:195-203.
3. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44.
4. Ho M, Garnett SP, Baur LA, et al. Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials. JAMA Pediatr 2013;167:759-68.
5. Alisi A, Nobili V. Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments. Nutrition 2012:722-6.
6. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009;15:6017-22.
7. Nobili V, Manco M, Devito R, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119-28.
8. Inge TH. Bariatric surgery for morbidly obese adolescents: is there a rationale for early intervention? GrowthHorm IGF Res 2006;16:S15-9.
9. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and costeffectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009;13:1-190215-357.
10. Schilling PL, Davis MM, Albanese CT, et al. National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg 2008;206:1-12.
11. Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts 2013;6: 449-68.
12. Hofmann B. Bariatric surgery for obese children and adolescents: a review of the moral challenges. BMC Medical Ethics 2013;14:18.
13. Michalsky M, Reichard K, Inge T, et al., American Society for Metabolic and Bariatric Surgery. ASMBS pediatric committee best practice guidelines. SurgObesRelat Dis 2012;8:1-7.
14. Fullmer MA, Abrams SH, Hrovat K, et al., National Association of Children's Hospitals and Related Institutions; North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Nutritional strategy for adolescents undergoing bariatric surgery: report of a working group of the Nutrition Committee of NASPGHAN/NACHRI. J Pediatr Gastroenterol Nutr 2012;54:125-35.
15. Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes 2013;2013:839275.
16. Michalsky M, Kramer RE, Fullmer MA, et al. Developing criteria for pediatric/adolescent bariatric surgery programs. Pediatrics 2011;128: S65-70.
17. Nobili V, Svegliati-Baroni G, Alisi A, et al. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 2013;58:1218-29.
18. Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced liver disease. Gastroenterology 2009; 137:532-40.
19. Chalasani N, Younossi Z, Lavine JE, et al., American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012;107:811-26.
20. Mummadi RR, Kasturi KS, Chennareddygair S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and metaanalysis. Clin Gastroenterol Hepatol 2008;6:1396-402.
21. Chavez-Tapia NC, Tellez-Avila FI, Barrientose-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 2010; (1).
22. ingrone G, Panunzi S, De Gaetano A. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-85.
23. Inge TH, Miyano G, Bean J, et al. Reversal of Type 2 Diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 2009;123:214-22.
24. Nobili V, Cutrera R, Liccardo D, et al. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. Am J Respir Crit Care Med 2014;189:66-76.
25. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50.
26. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-37.
27. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux en Y gastric bypass. J Am Coll Surgeons 2006;203:24-9.
28. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114:217-23.
29. Apovian CM, Baker C, Ludwig DS, et al. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005;13:274-82.
30. Pardee PE, Lavine JE, Schwimmer JB. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Semin Pediatr Surg 2009;18:144-51.
31. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006;44:458-65.
32. Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-5.
33. Chandra V, Dutta S, Albanese CT, et al. Clinical resolution of severely symptomatic pseudotumorcerebri after gastric bypass in an adolescent. Surg Obes Relat Dis 2007;3:198-200.
34. Goodman E, Daniels SR, Meigs JB, et al. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007;115:2316-22.
35. Loux TJ, Haricharan RN, Clements RH, et al. Health-related quality of life before and after bariatric surgery in adolescents. J Pediatr Surg 2008;43:1275-9.
36. Black JA, White B, Viner RM, et al. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev 2013;14:634-44.
37. Zeller MH, Modi AC, Noll JG, et al. Psychosocial functioning improves following adolescent bariatric surgery. Obes Silver Spring 2009;17:985-90.
38. Akamine AM, Ilias EJ. Why are psychological evaluation and preparation necessary for the patient candidate to bariatric surgery? Rev Assoc Med Bras 2013;59:316-7.
39. Kubik JF, Gill RS, Laffin M, et al. The impact of bariatric surgery on psychological health. J Obes 2013;2013:837-989.
40. Peterhänsel C, Petroff D, Klinitzke G, et al. Risk of completed suicide after bariatric surgery: a systematic review. Obes Rev 2013;14:369-82.
41. Rudolph A, Hilbert A. Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2013;14:292-302.
42. Kalarchian MA, Marcus MD, Levine MD, et al. Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis 2008;4:544-9.
43. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008;4:S109-84.
44. Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005;19:200-21.
45. Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 2007;150:12-7.
46. Evans HM, Shaikh MG, McKiernan PJ, et al. Acute fatty liver disease after suprasellar tumor resection. J Pediatr Gastroenterol Nutr 2004;39:288-91.
47. Crocker MK, Yanovski JA. Pediatric obesity: etiology and treatment. Pediatr Clin North Am 2011;58:1217-40.
48. Boza C, Gamboa C, Awruch D, et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surg Obes Relat Dis 2010;6:470-5.
49. Frezza EE, Chiriva-Internati M,Wachtel MS. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today 2008;38:481-3.
50. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006;20:859-63.
51. Treadwell JR, Sun F, Schoelles K. Systematic review and metaanalysis of bariatric surgery for pediatric obesity. Ann Surg 2008; 248:763-76.
52. Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obes Silver Spring 2009;17: 901-10.
53. Holterman AX, Browne A, Tussing L, et al. A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes. J Pediatr Surg 2010;45:74-9.
54. US Food and Drug Administration. Gastric banding. http://www.fda. gov/MedicalDevices/ProductsandMedicalProcedures/Implantsand Prosthetics/GastricBanding/default.htm. Accessed August 12, 2012.
55. Yitzhak A, Mizrahi S, Avinoach E. Laparoscopic gastric banding in adolescents. Obes Surg 2006;16:1318-22.
56. Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 2005;15:1469-75.
57. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. SurgEndosc 2006;20:859-63.
58. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg Today 2007;37:275-81.
59. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998;22:947-54.
60. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000;10:514-23.
61. Karmali S, Stoklossa CJ, Stadnyk J, et al. Bariatric surgery: a primer. Can Fam Physician 2010;56:873-9.
62. Sarkhosh K, Birch DW, Sharma A, et al. Complications associated with laparoscopic sleeve gastrectomy for morbid obesity: a surgeon's guide. Can J Surg 2013;56:347-52.
63. Till HK, Muensterer O, Keller A, et al. Laparoscopic sleeve gastrectomy achieves substantial weight loss in an adolescent girl with morbid obesity. Eur J Pediatr Surg 2008;18:47-9.
64. Till H, Bluher S, Hirsch W, et al. Efficacy of laparoscopic sleeve gastrectomy (LSG) as a stand-alone technique for children with morbid obesity. Obes Surg 2008;18:1047-9.
65. Landau Z, Karplus G, Hanukoglu A, et al. Laparoscopic sleeve gastrectomy (LSG) in adolescents with morbid obesity [in Hebrew]. Harefuah 2011;150:765-8.
66. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011;254: 410-20.
67. Angrisani L, Cutolo PP, Buchwald JN, et al. Laparoscopic reinforced sleeve gastrectomy: early results and complications. Obes Surg 2011;21:783-93.
68. Stroh C, Birk D, Flade-Kuthe R, et al., Bariatric Surgery Working Group. Results of sleeve gastrectomy-data from a nationwide survey on bariatric surgery in Germany. Obes Surg 2009;19:632-40.
69. Al-Sabah SK, Almazeedi SM, Dashti SA, et al. The efficacy of laparoscopic sleeve gastrectomy in treating adolescent obesity. Obes Surg 2015;25:50-4.
70. Galloro G, De Palma GD, Catanzano C, et al. Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity. Obes Surg 1999;9:68-71.
71. McFarland RJ, Grundy A, Gazet JC, et al. The intragastric balloon: a novel idea proved ineffective. Br J Surg 1987;74:137-9.
72. Hogan RB, Johnston JH, Long BW, et al. A double blind, randomized, sham controlled trial of the gastric bubble for obesity. Gastrointest Endosc 1989;35:381-5.
73. Meshkinpour H, Hsu D, Farivar S. Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology 1988;95:589-92.
74. Doldi SB, Micheletto G, Perrini MN, et al. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepatogastroenterology 2004;51:294-7.
75. Tottè E, Hendrickx L, Pauwels M, et al.Weight reduction by means of intragastric device: experience with the bioentericsintragastric balloon. Obes Surg 2001;11:519-23.
76. Genco A, Bruni T, Doldi SB, et al. Bioentericsintragastric balloon: the Italian experience with 2515 patients. Obes Surg 2005;15:1161-4.
77. Engert RB, Weiner R, Weiner S, et al. The gastric balloon: a retrospective cohort analysis of 634 patients. Obes Facts 2009;2: 24-6.
78. Stimac D, Majanovic SK, Turk T, et al. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg 2011;21:551-5.
79. Donadio F, Sburlati LF, Masserini B, et al. Metabolic parameters after BioEntericsIntragastric Balloon placement in obese patients. J Endocrinol Invest 2009;32:165-8.
80. De Peppo F, Di Giorgio G, Germani M, et al. BioEntericsintragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg 2008;18:1443-9.
81. Konopko-Zubrzycka M, Kowalska I, Wroblewski E, et al. The effect of intragastric balloon on serum lipids level in patients with morbid obesity. Pol Merkur Lekarski 2009;26:430-4.
82. Weiner R, Gutberlet H, Bockhorn H. Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy. Obes Surg 1999;9:261-4.
83. Loffredo A, Cappuccio M, De Luca M, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg 2001;11:330-3.
84. Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapyin the long-term management of obesity. Obes Surg 2012;22:565-71.
85. Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg 2008;18:989-92.
86. Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEntericsintragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010;71:927-33.
87. Herve J,Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005;15:864-70.
88. Saruc M, Boler D, Karaarslan M, et al. Intragastric balloon treatment of obesity must be combined with bariatric surgery: a pilot study in Turkey. Turk J Gastroenterol 2010;21:333-7.
89. Hodson RM, Zacharoulis D, Goutzamani E, et al. Management of obesity with the new intragastric balloon. Obes Surg 2001;11:327-9.
90. Nobili V, Della Corte C, Liccardo D, et al. Obalon intragastric balloon in the treatment of paediatric obesity: a pilot study. Pediatr Obes 2014 November 14 [Epub ahead of print].
91. De Peppo F, Di Giorgio G, Germani M, et al. BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg 2008;18:1443-9.
92. Ibele AR, Mattar SG. Adolescent bariatric surgery. Surg Clin North Am 2011;91:1339-51.
93. Papadia FS, Adami GF, Marinari GM, et al. Bariatric surgery in adolescents: a long-term follow-up study. Surg Obes Relat Dis 2007;3:465-8.
94. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition 2010;26:1031-7.
95. Xanthakos SA, Inge TH. Nutritional consequences of bariatric surgery. Curr Opin Clin Nutr Metab Care 2006;9:489-96.
96. Kaulfers AM, Bean JA, Inge TH, et al. Bone loss in adolescents after bariatric surgery. Pediatrics 2011;127:e956-61.
97. Cameron JLCA. Current Surgical Therapy. 10th ed. Philadelphia, PA: Elsevier Saunders; 2011.
98. Marceau P, Marceau S, Biron S, et al. Long-term experience with duodenal switch in adolescents. Obes Surg 2010;20:1609-16.
99. Xanthakos SA, Daniels SR, Inge TH. Bariatric surgery in adolescents: an update. Adolesc Med Clin 2006;17:589-612.
100. Xanthakos SA. Bariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axis. Pathophysiology 2008;15:135-46.
101. Lawson ML, Kirk S, Mitchell T, et al., Pediatric Bariatric Study Group. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006;41:137-43.
102. Rand CS, Macgregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J 1994;87:1208-13.
103. Inge TH, Zeller MH, Jenkins TM, et al. Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr 2014;168:47-53.
104. Lawson ML, Kirk S, Mitchell T, et al. One-year outcomes of Rouxen-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006;41:137-43.
105. Lee DY, Guend H, Park K, et al. Outcomes of laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastricbanding in adolescents. Obes Surg 2012;22:1859-64.
106. Göthberg G, Gronowitz E, Flodmark CE, et al. Laparoscopic Rouxen-Y gastric bypass in adolescents with morbid obesity-surgical aspects and clinical outcome. Semin Pediatr Surg 2014;23:11-6.
107. Mason ME, Jalagani H, Vinik AI. Metabolic complications of bariatric surgery: diagnosis and management issues. Gastroenterol Clin North Am 2005;34:25-33.
108. Brolin RE, Gorman JH, Gorman RC, et al. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg 1998;2:436-42.
109. Coates PS, Bernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity lead to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004;89:1061-5.
110. Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 2009;35:544-57.
111. Herpertz S, Kielmann R, Wolf AM, et al. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004;12:1554-69.
112. Kruger RS, Pricolo VE, Streeter TT, et al. A bariatric surgery center of excellence: operative trends and long-term outcomes. J Am Coll Surg 2014;218:1163-74.
113. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008;32 (suppl 7):S93-7.